Sudeep Pharma consolidated net profit rises 10.61% in the March 2026 quarter

Sales rise 15.73% to Rs 182.34 crore

Net profit of Sudeep Pharma rose 10.61% to Rs 48.88 crore in the quarter ended March 2026 as against Rs 44.19 crore during the previous quarter ended March 2025. Sales rose 15.73% to Rs 182.34 crore in the quarter ended March 2026 as against Rs 157.55 crore during the previous quarter ended March 2025.

For the full year,net profit rose 24.62% to Rs 172.89 crore in the year ended March 2026 as against Rs 138.73 crore during the previous year ended March 2025. Sales rose 27.94% to Rs 642.26 crore in the year ended March 2026 as against Rs 502.00 crore during the previous year ended March 2025.

Particulars	Quarter Ended			Year Ended
	Mar. 2026	Mar. 2025	% Var.	Mar. 2026	Mar. 2025	% Var.
Sales	182.34	157.55	16	642.26	502.00	28
OPM %	34.33	37.31	-	34.55	37.84	-
PBDT	66.58	60.68	10	242.88	193.44	26
PBT	62.69	57.85	8	228.07	182.85	25
NP	48.88	44.19	11	172.89	138.73	25

Powered by Capital Market - Live News